{"id":"https://openalex.org/W4385658036","doi":"https://doi.org/10.1097/01.hs9.0000970896.99126.2c","title":"P998: TRETINOIN AND CALCITRIOL ENHANCE TREATMENT REGIMENS FOR JUVENILE MYELOMONOCYTIC LEUKEMIA IN EX VIVO DRUG SENSITIVITY ASSAYS","display_name":"P998: TRETINOIN AND CALCITRIOL ENHANCE TREATMENT REGIMENS FOR JUVENILE MYELOMONOCYTIC LEUKEMIA IN EX VIVO DRUG SENSITIVITY ASSAYS","publication_year":2023,"publication_date":"2023-08-01","ids":{"openalex":"https://openalex.org/W4385658036","doi":"https://doi.org/10.1097/01.hs9.0000970896.99126.2c"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000970896.99126.2c","doi":"https://doi.org/10.1097/01.hs9.0000970896.99126.2c","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970896.99126.2c","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1097/01.hs9.0000970896.99126.2c","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028407091","display_name":"Elliot Stieglitz","orcid":"https://orcid.org/0000-0001-7032-4623","observed_orcids":["https://orcid.org/0000-0001-7032-4623"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210135903","display_name":"UCSF Benioff Children's Hospital","ror":"https://ror.org/03hwe2705","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135903"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elliot Stieglitz","raw_affiliation_strings":["UCSF Benioff Children\u2019s Hospital - San Francisco, San Francisco, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Benioff Children\u2019s Hospital - San Francisco, San Francisco, United States","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210135903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031373184","display_name":"Christine J. Gu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Gu","raw_affiliation_strings":["Notable Labs, Foster City, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, United States","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042546740","display_name":"Anukriti Dhar","orcid":"https://orcid.org/0000-0003-0788-397X","observed_orcids":["https://orcid.org/0000-0003-0788-397X"]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anukriti Dhar","raw_affiliation_strings":["Notable Labs, Foster City, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, United States","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020873605","display_name":"Juwita H\u00fcbner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210135903","display_name":"UCSF Benioff Children's Hospital","ror":"https://ror.org/03hwe2705","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135903"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juwita Huebner","raw_affiliation_strings":["UCSF Benioff Children\u2019s Hospital - San Francisco, San Francisco, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Benioff Children\u2019s Hospital - San Francisco, San Francisco, United States","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210135903"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083159350","display_name":"Kamran A. Ali","orcid":"https://orcid.org/0009-0006-6811-6175","observed_orcids":["https://orcid.org/0009-0006-6811-6175"]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kamran Ali","raw_affiliation_strings":["Notable Labs, Foster City, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, United States","institution_ids":["https://openalex.org/I4210130485"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019176812","display_name":"Markus Daniel Lacher","orcid":"https://orcid.org/0000-0003-2597-5704","observed_orcids":["https://orcid.org/0000-0003-2597-5704"]},"institutions":[{"id":"https://openalex.org/I4210130485","display_name":"Notable Labs (United States)","ror":"https://ror.org/03b9h7664","country_code":"US","type":"company","lineage":["https://openalex.org/I4210130485"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Markus Lacher","raw_affiliation_strings":["Notable Labs, Foster City, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Notable Labs, Foster City, United States","institution_ids":["https://openalex.org/I4210130485"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"S3","first_page":"e991262c","last_page":"e991262c"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.7045999765396118,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.7045999765396118,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.18639999628067017,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.020800000056624413,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/juvenile-myelomonocytic-leukemia","display_name":"juvenile myelomonocytic leukemia","score":1.0},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.9449999928474426},{"id":"https://openalex.org/keywords/1-25-dihydroxyvitamin-d3","display_name":"1,25-dihydroxyvitamin D3","score":0.9679999947547913},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.8629999756813049},{"id":"https://openalex.org/keywords/drug-combination-screening","display_name":"drug combination screening","score":0.7260000109672546},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.4519999921321869},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.7110000252723694},{"id":"https://openalex.org/keywords/ras-mutations","display_name":"RAS mutations","score":0.6510000228881836},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.8539999723434448},{"id":"https://openalex.org/keywords/precision-medicine","display_name":"precision medicine","score":0.4909999966621399},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.3919999897480011}],"concepts":[{"id":"https://openalex.org/C2779157977","wikidata":"https://www.wikidata.org/wiki/Q2578247","display_name":"Juvenile myelomonocytic leukemia","level":4,"score":0.6159734725952148},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5643397569656372},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5052233338356018},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.5003783702850342},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.4889043867588043},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47882845997810364},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.45530954003334045},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44868433475494385},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.42257586121559143},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.42152392864227295},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41227665543556213},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.3679715394973755},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33091408014297485},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.29118141531944275},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.2531990110874176},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.16800233721733093},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1672792136669159},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.12504512071609497},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000970896.99126.2c","doi":"https://doi.org/10.1097/01.hs9.0000970896.99126.2c","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970896.99126.2c","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10431440","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10431440","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10431440/pdf/hs9-7-e991262c.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:3c7a4d92d926426fb64f93fce222c3b6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3c7a4d92d926426fb64f93fce222c3b6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 7, p e991262c (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000970896.99126.2c","doi":"https://doi.org/10.1097/01.hs9.0000970896.99126.2c","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1097/01.hs9.0000970896.99126.2c","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385658036.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388554511","https://openalex.org/W4319072544","https://openalex.org/W2117478368","https://openalex.org/W7154513496","https://openalex.org/W4389243160","https://openalex.org/W4402903348","https://openalex.org/W4388522386","https://openalex.org/W7101089545","https://openalex.org/W4389246656","https://openalex.org/W2587614664"],"abstract_inverted_index":{"Topic:":[0],"15.":[1],"Myeloproliferative":[2],"neoplasms":[3],"-":[4],"Biology":[5],"&":[6],"Translational":[7],"Research":[8],"Background:":[9],"Juvenile":[10],"myelomonocytic":[11],"leukemia":[12],"(JMML)":[13],"is":[14,42,52,79],"a":[15,32,80,104,218,262,323,405,442],"rare":[16],"and":[17,26,66,121,160,189,234,278,294,325,382],"aggressive":[18],"pediatric":[19],"malignancy":[20],"with":[21,192,210,261,279,295,307,321,333,389,500],"features":[22],"of":[23,174,225,232,235,240,252,257,282,298,310,340,361,394,417,441,462,477],"both":[24,322],"myelodysplasia":[25],"myeloproliferation.":[27],"In":[28],"nearly":[29],"all":[30,202],"cases,":[31],"RAS":[33],"pathway":[34],"gene":[35],"(PTPN11,":[36],"NRAS,":[37],"KRAS,":[38],"NF1,":[39],"or":[40,126,306,337,352,399,483,486,505],"CBL)":[41],"mutated.":[43],"For":[44,151,259,318],"most":[45],"patients,":[46],"the":[47,140,171,175,183,187,193,222,249,264,280,296,308,319,343,367,378,390,395,415,418,426,439,459,470,475,492],"only":[48,501],"curative":[49],"treatment":[50,332,388,499],"option":[51],"hematopoietic":[53],"stem":[54],"cell":[55],"transplantation":[56],"(HSCT).":[57],"As":[58],"pre-HSCT":[59,87,456],"treatments,":[60],"fludarabine":[61],"(FLU)":[62],"plus":[63],"cytarabine":[64],"(ARA-C)":[65],"5-azacitidine":[67],"(5-AZA)":[68],"monotherapy":[69],"are":[70,74],"commonly":[71],"used":[72,454],"but":[73],"not":[75],"universally":[76],"effective.":[77],"There":[78],"need":[81],"to":[82,134,146,157,162,169,349,355,363,372,401,410,479,484,488,498],"identify":[83,135],"additional,":[84],"more":[85,450],"effective":[86,451],"regimens":[88],"in":[89,100,229,237,254,404,469],"JMML.":[90],"Aims:":[91],"We":[92,114,205,436],"aimed":[93],"at":[94],"identifying":[95,446],"novel,":[96],"anti-leukemic":[97,223,250],"drug":[98,117,208,447],"combinations":[99,118,136,209,448],"JMML":[101,132,455,464],"by":[102,276,284,292,300,312,421,432],"employing":[103],"high-throughput,":[105],"flow":[106],"cytometry-based":[107],"predictive":[108],"precision":[109],"medicine":[110],"platform":[111],"(PPMP).":[112],"Methods:":[113],"screened":[115],"130":[116],"(DCs)":[119],"(dual":[120],"triple)":[122],"on":[123],"peripheral":[124],"blood":[125],"bone":[127],"marrow":[128],"samples":[129,152,465],"from":[130,347,353,370],"29":[131],"patients":[133,233,260,320],"that":[137,474],"significantly":[138],"reduced":[139,269,342,366],"vehicle-normalized":[141],"blast":[142,495],"(NormBlast)":[143],"counts":[144,327,496],"relative":[145],"their":[147],"individual":[148],"components":[149],"(ICs).":[150],"demonstrating":[153],"this":[154],"effect":[155,165,178,251,287,303,315,383,408],"(referred":[156],"as":[158,182,270],"\u201cDC-advantage\u201d)":[159],"belonging":[161],"such":[163],"combinations,":[164,176],"sizes":[166,384],"were":[167,268],"calculated":[168],"quantify":[170],"combinatorial":[172,211],"effects":[173,224],"whereby":[177],"size":[179],"was":[180,199,429],"defined":[181],"NormBlast":[184,195,266,326,345,368,380,419],"difference":[185],"between":[186],"DC":[188],"its":[190],"IC":[191],"lowest":[194],"count.":[196],"Informed":[197],"consent":[198],"obtained":[200],"for":[201,272,290,445],"patients.":[203,241,258],"Results:":[204],"identified":[206],"37":[207],"effects.":[212],"Tretinoin":[213],"(TRET,":[214],"all-trans":[215],"retinoic":[216,512],"acid),":[217],"differentiation":[219],"agent,":[220,247],"enhanced":[221,248],"FLU":[226,273,334,411,422,480,502],"+":[227,274,335,412,423,481,503],"ARA-C":[228,275,336,424,482],"91%":[230,285],"(21/23)":[231],"5-AZA":[236,253,291,364,402,433],"78%":[238],"(21/27)":[239],"Similarly,":[242],"calcitriol":[243,487],"(CALC),":[244],"another":[245],"differentiating":[246,396,427],"85%":[255],"(23/27)":[256],"DC-advantage,":[263],"median":[265,344],"values":[267,346,381],"follows:":[271],"88%,":[277],"inclusion":[281,297,309],"TRET":[283,299,341],"(median":[286,302,314],"size:":[288,304,316],"3%);":[289],"27%,":[293],"51%":[301],"15%),":[305],"CALC,":[311],"46%":[313],"13%).":[317],"DC-advantage":[324],">30%":[328],"following":[329,385],"ex":[330,386,467,493],"vivo":[331,387,468,494],"5-AZA,":[338,485,489,506],"addition":[339,360,476],"32%":[348],"28%":[350],"(n=3),":[351],"73%":[354,371],"49%":[356],"(n=21),":[357],"respectively.":[358],"The":[359],"CALC":[362],"also":[365],"value,":[369],"54%":[373],"(n=23).":[374],"Figure":[375],"1":[376],"outlines":[377],"respective":[379],"indicated":[391],"conditions.":[392],"Addition":[393],"agent":[397,428],"(TRET":[398],"CALC)":[400],"resulted":[403],"larger":[406],"blast-reduction":[407],"compared":[409,497],"ARA-C.":[413],"However,":[414],"reduction":[416],"count":[420],"without":[425],"greater":[430],"than":[431,452],"alone.":[434],"Summary/Conclusion:":[435],"have":[437],"shown":[438],"utility":[440],"high-throughput":[443],"PPMP":[444],"potentially":[449],"currently":[453],"regimens.":[457],"Using":[458],"largest":[460],"collection":[461],"primary":[463],"tested":[466],"literature,":[471],"we":[472],"highlight":[473],"tretinoin":[478],"further":[490],"reduces":[491],"ARA-C,":[504],"respectively.Keywords:":[507],"JMML,":[508],"Ex":[509],"vivo,":[510],"ALL-trans":[511],"acid":[513],"(ATRA),":[514],"Drug":[515],"sensitivity":[516]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2023-08-09T00:00:00"}